Overexpression of MutSα complex proteins predicts poor prognosis in oral squamous cell carcinoma

Medicine (United States)

Volumn 95, Issue 22, 2016, Pages

  Wagner, Vivian Petersen ^a,b   Webber, Liana Preto ^a,b   Salvadori, Gabriela ^c   Meurer, Luise ^b   Fonseca, Felipe Paiva ^d   Castilho, Rogério Moraes ^e   Squarize, Cristiane Helena ^e   Vargas, Pablo Agustin ^d   Martins, Manoela Domingues ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF CAMPINAS   (Brazil)

^e UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MSH2; PROTEIN MSH6; PROTEIN MUTS; PROTEIN MUTS ALPHA; TUMOR MARKER; UNCLASSIFIED DRUG; DNA;

ADULT; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHEEK MUCOSA; COHORT ANALYSIS; CORRELATION ANALYSIS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIP CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MISMATCH REPAIR; MOUTH SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SURVIVAL RATE; TISSUE MICROARRAY; TONGUE CARCINOMA; TUMOR RECURRENCE; TUMOR VOLUME; BIOSYNTHESIS; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUTH NEOPLASMS; MULTICENTER STUDY;

CARCINOMA, SQUAMOUS CELL; DNA MISMATCH REPAIR; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MOUTH NEOPLASMS; MUTS HOMOLOG 2 PROTEIN; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 84975223456     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003725     Document Type: Article

References (29)

1. Mascolo M, Siano M, Ilardi G, et al. Epigenetic disregulation in oral cancer. Int J Mol Sci. 2012; 13: 2331-2353
2. Li GM. Mechanisms and functions of DNA mismatch repair. Cell Res. 2008; 18: 85-98
3. Stark AM, Doukas A, Hugo HH, et al. Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma. Neurol Res. 2015; 37: 95-105
4. Edelbrock MA, Kaliyaperumal S, Williams KJ. Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activities. Mutat Res. 2013: 743-74453-66
5. Modrich P, Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu Rev Biochem. 1996; 65: 101-133
6. Peltomäki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol. 2003; 21: 1174-1179
7. Uehara H, Miyamoto M, Kato K, et al. Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma. J Surg Oncol. 2005; 92: 109-115
8. Caldeira PC, Abreu MH, Batista AC, et al. hMLH1 immunoexpression is related to the degree of epithelial dysplasia in oral leukoplakia. J Oral Pathol Med. 2011; 40: 153-159
9. Jessri M, Dalley AJ, Farah CS. hMSH6: a potential diagnostic marker for oral carcinoma in situ. J Clin Pathol. 2015; 68: 86-90
10. Souza LR, Fonseca-Silva T, Pereira CS, et al. Immunohistochemical analysis of p53, APE1, hMSH2 and ERCC1 proteins in actinic cheilitis and lip squamous cell carcinoma. Histopathology. 2011; 58: 352-360
11. Sarmento DJ, de Almeida WL, Miguel MC, et al. Immunohistochemical analysis of mismatch proteins in carcinogenesis of the lower lip. Histopathology. 2013; 63: 371-377
12. Nunn J, Nagini S, Risk JM, et al. Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck. Oral Oncol. 2003; 39: 115-129
13. Demokan S, Suoglu Y, Demir D, et al. Microsatellite instability and methylation of the DNA mismatch repair genes in head and neck cancer. Ann Oncol. 2006; 17: 995-999
14. Czerninski R, Krichevsky S, Ashhab Y, et al. Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma. Oral Dis. 2009; 15: 206-213
15. Fernandes AM, Ramos-Jorge ML, Cardoso SV, et al. Immunoexpression of hMSH2 and hMLH1 in oral squamous cell carcinoma and its relationship to histological grades of malignancy. J Oral Pathol Med. 2008; 37: 543-548
16. Alvino E, Passarelli F, Cannavò E, et al. High expression of the mismatch repair protein MSH6 is associated with poor patient survival in melanoma. Am J Clin Pathol. 2014; 142: 121-132
17. Jentzsch T, Robl B, Husmann M, et al. Expression of MSH2 and MSH6 on a tissue microarray in patients with osteosarcoma. Anticancer Res. 2014; 34: 6961-6972
18. Ting S, Mairinger FD, Hager T, et al. ERCC1, MLH1, MSH2, MSH6, and (III-Tubulin: resistance proteins associated with response and outcome to platinum-based chemotherapy in malignant pleural mesothelioma. Clin Lung Cancer. 2013; 14: 558-567e3
19. Bryne M, Koppang HS, Lilleng R, et al. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol. 1992; 166: 375-381
20. Fonseca FP, de Andrade BA, Rangel AL, et al. Tissue microarray is a reliable method for immunohistochemical analysis of pleomorphic adenoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014; 117: 81-88
21. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004; 101: 3-27
22. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127: 2893-2917
23. Kato M, Takano M, Miyamoto M, et al. DNA mismatch repairrelated protein loss as a prognostic factor in endometrial cancers. J Gynecol Oncol. 2015; 26: 40-45
24. Jascur T, Boland CR. Structure and function of the components of the human DNA mismatch repair system. Int J Cancer. 2006; 119: 2030-2035
25. Marra G, Chang CL, Laghi LA, et al. Expression of human MutS homolog 2 (hMSH2) protein in resting and proliferating cells. Oncogene. 1996; 13: 2189-2196
26. Christmann M, Tomicic MT, Kaina B. Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutSalpha mismatchbinding activity. Nucleic Acids Res. 2002; 30: 1959-1966
27. Mardis ER. Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet. 2008; 9: 387-402
28. Agrawal N, Frederick MJ, Pickering CR, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011; 333: 1154-1157
29. Stransky N, Egloff AM, Tward AD, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011; 333: 1157-1160